CD1d- and MR1-restricted invariant T cells: of mice and men

Current Opinion in Immunology

Volumn 18, Issue 5, 2006, Pages 519-526

  Treiner, Emmanuel ^a   Lantz, Olivier ^b  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY MOLECULE RELATED 1; UNCLASSIFIED DRUG;

ALLERGY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL FLORA; CELL SELECTION; CELLULAR IMMUNITY; COMMENSALISM; DENDRITIC CELL; GENETIC CONSERVATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION; INFLAMMATION; INTESTINE; LAMINA PROPRIA; MESENTERY LYMPH NODE; NATURAL KILLER T CELL; NONHUMAN; ONTOGENY; PHYLOGENY; REVIEW; T LYMPHOCYTE; TISSUE DISTRIBUTION; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD1; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTESTINAL MUCOSA; KILLER CELLS, NATURAL; MALE; MICE; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 33748163913     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.07.001     Document Type: Review

References (88)

1. Matsuda J.L., and Gapin L. Developmental program of mouse Vα14i NKT cells. Curr Opin Immunol 17 (2005) 122-130
2. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23 (2005) 877-900
3. Treiner E., Duban L., Moura I.C., Hansen T., Gilfillan S., and Lantz O. Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect 7 (2005) 552-559
4. Treiner E., Duban L., Bahram S., Radosavljevic M., Wanner V., Tilloy F., Affaticati P., Gilfillan S., and Lantz O. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422 (2003) 164-169
5. Lambolez F., Arcangeli M.L., Joret A.M., Pasqualetto V., Cordier C., Di Santo J.P., Rocha B., and Ezine S. The thymus exports long-lived fully committed T cell precursors that can colonize primary lymphoid organs. Nat Immunol 7 (2006) 76-82
6. Tilloy F., Treiner E., Park S.H., Garcia C., Lemonnier F., de la Salle H., Bendelac A., Bonneville M., and Lantz O. An invariant T cell receptor α chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J Exp Med 189 (1999) 1907-1921
7. Miley M.J., Truscott S.M., Yu Y.Y., Gilfillan S., Fremont D.H., Hansen T.H., and Lybarger L. Biochemical features of the MHC-related protein 1 consistent with an immunological function. J Immunol 170 (2003) 6090-6098
8. Huang S., Gilfillan S., Cella M., Miley M.J., Lantz O., Lybarger L., Fremont D.H., and Hansen T.H. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem 280 (2005) 21183-21193. This is the first study to suggest that MAIT hybridoma recognize a MR1-bound ligand.
9. Okamoto N., Kanie O., Huang Y.Y., Fujii R., Watanabe H., and Shimamura M. Synthetic α-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Vα19-Jα26 TCR α chain. Chem Biol 12 (2005) 677-683
10. Jameson J., Ugarte K., Chen N., Yachi P., Fuchs E., Boismenu R., and Havran W.L. A role for skin γδ T cells in wound repair. Science 296 (2002) 747-749
11. Kawachi I., Maldonado J., Strader C., and Gilfillan S. MR1-restricted Vα 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol 176 (2006) 1618-1627
12. Illes Z., Shimamura M., Newcombe J., Oka N., and Yamamura T. Accumulation of Vα7.2-Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol 16 (2004) 223-230
13. Jayawardena-Wolf J., Benlagha K., Chiu Y.H., Mehr R., and Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15 (2001) 897-908
14. Moody D.B., and Porcelli S.A. CD1 trafficking: invariant chain gives a new twist to the tale. Immunity 15 (2001) 861-865
15. Honey K., Benlagha K., Beers C., Forbush K., Teyton L., Kleijmeer M.J., Rudensky A.Y., and Bendelac A. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat Immunol 3 (2002) 1069-1074
16. Stanic A.K., De Silva A.D., Park J.J., Sriram V., Ichikawa S., Hirabyashi Y., Hayakawa K., Van Kaer L., Brutkiewicz R.R., and Joyce S. Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-d-glucosylceramide synthase deficiency. Proc Natl Acad Sci USA 100 (2003) 1849-1854
17. Zhou D., Cantu III C., Sagiv Y., Schrantz N., Kulkarni A.B., Qi X., Mahuran D.J., Morales C.R., Grabowski G.A., Benlagha K., et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303 (2004) 523-527
18. Kang S.J., and Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 5 (2004) 175-181
19. Brozovic S., Nagaishi T., Yoshida M., Betz S., Salas A., Chen D., Kaser A., Glickman J., Kuo T., Little A., et al. CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med 10 (2004) 535-539
20. Dougan S.K., Salas A., Rava P., Agyemang A., Kaser A., Morrison J., Khurana A., Kronenberg M., Johnson C., Exley M., et al. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med 202 (2005) 529-539
21. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789
22. Fischer K., Scotet E., Niemeyer M., Koebernick H., Zerrahn J., Maillet S., Hurwitz R., Kursar M., Bonneville M., Kaufmann S.H., et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA 101 (2004) 10685-10690
23. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., and Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 189 (1999) 1973-1980
24. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu III C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434 (2005) 525-529. This study as well as [25] and [26] identify some of the exogenous ligands - α-glucuronosyl and a galacturonosyl ceramide - which activate the canonical iTCRα14 NKT cells. In addition, it is shown that other bacteria can activate NKT cells by upregulating the endogenous ligand iGb3 by way of a TLR-dependent mechanism.
25. Sriram V., Du W., Gervay-Hague J., and Brutkiewicz R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 35 (2005) 1692-1701
26. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., Tsuji M., Kawahara K., Wong C.H., and Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434 (2005) 520-525
27. Brigl M., Bry L., Kent S.C., Gumperz J.E., and Brenner M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4 (2003) 1230-1237
28. Skold M., Xiong X., Illarionov P.A., Besra G.S., and Behar S.M. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J Immunol 175 (2005) 3584-3593
29. Mallevaey T., Zanetta J.P., Faveeuw C., Fontaine J., Maes E., Platt F., Capron M., Leite-de-Moraes M., and Trottein F. Activation of invariant NKT cells by the helminth parasite Schistosoma mansoni. J Immunol 176 (2006) 2476-2485
30. + NKT cells participate in the early response to enteric Listeria monocytogenes infection. J Immunol 175 (2005) 1137-1144
31. + T cells by CD1-expressing cortical thymocytes. J Exp Med 182 (1995) 2091-2096
32. Egawa T., Eberl G., Taniuchi I., Benlagha K., Geissmann F., Hennighausen L., Bendelac A., and Littman D.R. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22 (2005) 705-716
33. + T cells. Eur J Immunol 27 (1997) 1576-1579
34. Benlagha K., Wei D.G., Veiga J., Teyton L., and Bendelac A. Characterization of the early stages of thymic NKT cell development. J Exp Med 202 (2005) 485-492
35. - T cells in mice and humans. J Exp Med 180 (1994) 1097-1106
36. + TCRαβ cell development. Eur J Immunol 29 (1999) 1966-1971
37. Wei D.G., Lee H., Park S.H., Beaudoin L., Teyton L., Lehuen A., and Bendelac A. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med 202 (2005) 239-248
38. Zimmer M.I., Colmone A., Felio K., Xu H., Ma A., and Wang C.R. A cell-type specific CD1d expression program modulates invariant NKT cell development and function. J Immunol 176 (2006) 1421-1430
39. Gadue P., Morton N., and Stein P.L. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J Exp Med 190 (1999) 1189-1196
40. Eberl G., Lowin-Kropf B., and MacDonald H.R. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J Immunol 163 (1999) 4091-4094
41. Pasquier B., Yin L., Fondaneche M.C., Relouzat F., Bloch-Queyrat C., Lambert N., Fischer A., de Saint-Basile G., and Latour S. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med 201 (2005) 695-701
42. Nichols K.E., Hom J., Gong S.Y., Ganguly A., Ma C.S., Cannons J.L., Tangye S.G., Schwartzberg P.L., Koretzky G.A., and Stein P.L. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med 11 (2005) 340-345. This study as well as [41] and [43] show the involvement of SAP, and therefore probably of a SLAM family molecule member, in the development of NTK cells. In this article, it is demonstrated that SAP deficiency acts through a NKT cell intrinsic mechanism.
43. Chung B., Aoukaty A., Dutz J., Terhorst C., and Tan R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J Immunol 174 (2005) 3153-3157
44. Borowski C., and Bendelac A. Signaling for NKT cell development: the SAP-FynT connection. J Exp Med 201 (2005) 833-836
45. Schmieg J., Yang G., Franck R.W., Van Rooijen N., and Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci USA 102 (2005) 1127-1132
46. Bezbradica J.S., Stanic A.K., Matsuki N., Bour-Jordan H., Bluestone J.A., Thomas J.W., Unutmaz D., Van Kaer L., and Joyce S. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J Immunol 174 (2005) 4696-4705
47. •] describe the structure of several exogenous ligands bound to CD1d. Binding characteristics are also shown. These features might explain some of the differential biological effects of these compounds.
48. •].
49. •].
50. Gadola S.D., Koch M., Marles-Wright J., Lissin N.M., Shepherd D., Matulis G., Harlos K., Villiger P.M., Stuart D.I., Jakobsen B.K., et al. Structure and binding kinetics of three different human CD1d-α-galactosylceramide-specific T cell receptors. J Exp Med 203 (2006) 699-710
51. Kjer-Nielsen L., Borg N.A., Pellicci D.G., Beddoe T., Kostenko L., Clements C.S., Williamson N.A., Smyth M.J., Besra G.S., Reid H.H., et al. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J Exp Med 203 (2006) 661-673
52. Cantu III C., Benlagha K., Savage P.B., Bendelac A., and Teyton L. The paradox of immune molecular recognition of α-galactosylceramide: low affinity, low specificity for CD1d, high affinity for αβ TCRs. J Immunol 170 (2003) 4673-4682
53. Schumann J., Mycko M.P., Dellabona P., Casorati G., and MacDonald H.R. Cutting edge: influence of the TCR Vβ domain on the selection of semi-invariant NKT cells by endogenous ligands. J Immunol 176 (2006) 2064-2068
54. Van Kaer L. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 5 (2005) 31-42
55. Yang J.Q., Saxena V., Xu H., Van Kaer L., Wang C.R., and Singh R.R. Repeated α-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J Immunol 171 (2003) 4439-4446
56. Yang J.Q., Singh A.K., Wilson M.T., Satoh M., Stanic A.K., Park J.J., Hong S., Gadola S.D., Mizutani A., Kakumanu S.R., et al. Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J Immunol 171 (2003) 2142-2153
57. Forestier C., Molano A., Im J.S., Dutronc Y., Diamond B., Davidson A., Illarionov P.A., Besra G.S., and Porcelli S.A. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand black x New Zealand white) F1 mice. J Immunol 175 (2005) 763-770
58. Zeng D., Liu Y., Sidobre S., Kronenberg M., and Strober S. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest 112 (2003) 1211-1222
59. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., and Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 194 (2001) 1789-1799
60. H2 bias of natural killer T cells. Nature 413 (2001) 531-534
61. Teige A., Teige I., Lavasani S., Bockermann R., Mondoc E., Holmdahl R., and Issazadeh-Navikas S. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J Immunol 172 (2004) 186-194
62. Kim H.Y., Kim H.J., Min H.S., Kim S., Park W.S., Park S.H., and Chung D.H. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production. J Exp Med 201 (2005) 41-47
63. + T regulatory cells in the prevention of autoimmune myasthenia. J Immunol 175 (2005) 7898-7904
64. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., Taniguchi M., Grusby M.J., DeKruyff R.H., and Umetsu D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 9 (2003) 582-588
65. Araujo L.M., Lefort J., Nahori M.A., Diem S., Zhu R., Dy M., Leite-de-Moraes M.C., Bach J.F., Vargaftig B.B., and Herbelin A. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. Eur J Immunol 34 (2004) 327-335
66. Lisbonne M., Diem S., de Castro Keller A., Lefort J., Araujo L.M., Hachem P., Fourneau J.M., Sidobre S., Kronenberg M., Taniguchi M., et al. Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 171 (2003) 1637-1641
67. + T cells. Proc Natl Acad Sci USA 103 (2006) 2782-2787
68. Hachem P., Lisbonne M., Michel M.L., Diem S., Roongapinun S., Lefort J., Marchal G., Herbelin A., Askenase P.W., Dy M., et al. α-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-γ. Eur J Immunol 35 (2005) 2793-2802
69. Parekh V.V., Wilson M.T., Olivares-Villagomez D., Singh A.K., Wu L., Wang C.R., Joyce S., and Van Kaer L. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 115 (2005) 2572-2583
70. + T cells upon CD226 engagement. J Immunol 175 (2005) 4914-4926
71. Smyth M.J., Crowe N.Y., Hayakawa Y., Takeda K., Yagita H., and Godfrey D.I. NKT cells - conductors of tumor immunity?. Curr Opin Immunol 14 (2002) 165-171
72. Crowe N.Y., Coquet J.M., Berzins S.P., Kyparissoudis K., Keating R., Pellicci D.G., Hayakawa Y., Godfrey D.I., and Smyth M.J. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 202 (2005) 1279-1288. This study dissects the involvement of distinct subsets of CD1d-restricted T cells in promoting or inhibiting antitumor immunity.
73. Seino K., and Taniguchi M. Functionally distinct NKT cell subsets and subtypes. J Exp Med 202 (2005) 1623-1626
74. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., Carbone D.P., Paul W.E., and Berzofsky J.A. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1 (2000) 515-520
75. Terabe M., Swann J., Ambrosino E., Sinha P., Takaku S., Hayakawa Y., Godfrey D.I., Ostrand-Rosenberg S., Smyth M.J., and Berzofsky J.A. A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 202 (2005) 1627-1633
76. Fujii S., Shimizu K., Smith C., Bonifaz L., and Steinman R.M. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198 (2003) 267-279
77. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171 (2003) 5140-5147
78. + T-cell response to transplanted tumors that express the same antigen. Most interestingly, the adjuvant properties of NKT cells provide strong immunity against an orally administered antigen.
79. Silk J.D., Hermans I.F., Gileadi U., Chong T.W., Shepherd D., Salio M., Mathew B., Schmidt R.R., Lunt S.J., Williams K.J., et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 114 (2004) 1800-1811
80. Smyth M.J., Wallace M.E., Nutt S.L., Yagita H., Godfrey D.I., and Hayakawa Y. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J Exp Med 201 (2005) 1973-1985
81. + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103 (2004) 383-389
82. Chang D.H., Osman K., Connolly J., Kukreja A., Krasovsky J., Pack M., Hutchinson A., Geller M., Liu N., Annable R., et al. Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J Exp Med 201 (2005) 1503-1517
83. Nakai Y., Iwabuchi K., Fujii S., Ishimori N., Dashtsoodol N., Watano K., Mishima T., Iwabuchi C., Tanaka S., Bezbradica J.S., et al. Natural killer T cells accelerate atherogenesis in mice. Blood 104 (2004) 2051-2059
84. Tupin E., Nicoletti A., Elhage R., Rudling M., Ljunggren H.G., Hansson G.K., and Berne G.P. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 199 (2004) 417-422
85. Diao H., Kon S., Iwabuchi K., Kimura C., Morimoto J., Ito D., Segawa T., Maeda M., Hamuro J., Nakayama T., et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21 (2004) 539-550
86. Heller F., Fuss I.J., Nieuwenhuis E.E., Blumberg R.S., and Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17 (2002) 629-638
87. Fuss I.J., Heller F., Boirivant M., Leon F., Yoshida M., Fichtner-Feigl S., Yang Z., Exley M., Kitani A., Blumberg R.S., et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113 (2004) 1490-1497
88. + NKT cells in germ-free mice. Eur J Immunol 30 (2000) 620-625